SCHEMBL14927080

SCHEMBL14927080

Cc1cc2cc(-c3cccc(-c4ccccc4)c3)[nH]c(=O)c2cc1C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PARP1 P09874 3/20 0.47
▸ KDM4E B2RXH2 7/20 0.46
▸ GAA P10253 3/20 0.46
▸ TNKS2 Q9H2K2 3/20 0.44
▸ TNKS O95271 3/20 0.44
▸ ALDH1A1 P00352 3/20 0.43
▸ HPGD P15428 2/20 0.43
▸ NPC1 O15118 2/20 0.43
▸ RAB9A P51151 2/20 0.43
▸ MAPT P10636 2/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ CYP3A4 P08684 2/20 0.42
▸ POLB P06746 1/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ F2 P00734 1/20 0.41
▸ F10 P00742 1/20 0.41
▸ PLG P00747 1/20 0.41
▸ PLAU P00749 1/20 0.41
▸ PRSS1 P07477 1/20 0.41
▸ CYP1A2 P05177 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14927077 0.94 KDM4E (0.46) PARP1KDM4EGAATNKS2TNKS
SCHEMBL16499568 0.83 PDE10A (0.47) PARP1KDM4ETNKS2TNKSALDH1A1
SCHEMBL9986595 0.83 PDE10A (0.47) PARP1KDM4ETNKS2TNKSALDH1A1
SCHEMBL14927044 0.79 KMT2A (0.40) PARP1TNKS2TNKSNPC1RAB9A
SCHEMBL12071547 0.75 PDE3B (0.48) KDM4ETNKS2TNKSALDH1A1HPGD
SCHEMBL28629567 0.75 KDM4E (0.59) PARP1KDM4EGAATNKS2TNKS
SCHEMBL30160749 0.75 KDM4E (0.59) PARP1KDM4EGAATNKS2TNKS
SCHEMBL15775395 0.73 PARP1 (0.67) PARP1KDM4EGAATNKS2TNKS
SCHEMBL31014299 0.73 PARP1 (0.67) PARP1KDM4EGAATNKS2TNKS
SCHEMBL31611876 0.73 TNKS (0.51) PARP1KDM4ETNKS2TNKSALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8933096-B2 Antimicrobial agents Rugers, The State University of New Jersey (US) 2015-01-13 — — US disclosed
US-20130116278-A1 ANTIMICROBIAL AGENTS RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY 2013-05-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130116278-A1 ANTIMICROBIAL AGENTS MRPL21, ARG1, RPP30 PARP1 2353/4885KDM4E 2572/4885GAA 2760/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback